Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Beer

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Lancet (London, England)|October 25, 2003
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialMichael Henke, Roland Laszig, Christian Rübe, et al.
Neuroendocrinology|January 1, 1986
Hypothalamic prolactin: characterization by radioimmunoassay and bioassay and response to hypophysectomy and restraint stressN V Emanuele, L Metcalfe, L Wallock, et al.
Brain Research|September 22, 1987
Extrahypothalamic brain prolactin: characterization and evidence for independence from pituitary prolactinN V Emanuele, L Metcalfe, L Wallock, et al.
Neuroendocrinology|March 1, 1989
Presence of prolactin-like immunoreactivity and bioactivity in rat spinal cordN V Emanuele, N Azad, J P Luckey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Prolactin-dependent mitogenesis in Nb 2 node lymphoma cells: effects of immunosuppressive cyclopeptidesD H Russell, A R Buckley, D W Montgomery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapyPia Huguenin, Karl T Beer, Abdelkarim Allal, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer NetworkPirus Ghadjar, Johannes H Kaanders, Philipp Poortmans, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Lancet (London, England)|October 25, 2003
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialMichael Henke, Roland Laszig, Christian Rübe, et al.
Neuroendocrinology|January 1, 1986
Hypothalamic prolactin: characterization by radioimmunoassay and bioassay and response to hypophysectomy and restraint stressN V Emanuele, L Metcalfe, L Wallock, et al.
Brain Research|September 22, 1987
Extrahypothalamic brain prolactin: characterization and evidence for independence from pituitary prolactinN V Emanuele, L Metcalfe, L Wallock, et al.
Neuroendocrinology|March 1, 1989
Presence of prolactin-like immunoreactivity and bioactivity in rat spinal cordN V Emanuele, N Azad, J P Luckey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Prolactin-dependent mitogenesis in Nb 2 node lymphoma cells: effects of immunosuppressive cyclopeptidesD H Russell, A R Buckley, D W Montgomery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapyPia Huguenin, Karl T Beer, Abdelkarim Allal, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer NetworkPirus Ghadjar, Johannes H Kaanders, Philipp Poortmans, et al.
Pageof 6